Yousif Capital Management LLC Sells 531 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Yousif Capital Management LLC trimmed its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 2.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,661 shares of the medical device company’s stock after selling 531 shares during the quarter. Yousif Capital Management LLC’s holdings in Cooper Companies were worth $1,899,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also added to or reduced their stakes in COO. Ashton Thomas Securities LLC bought a new stake in Cooper Companies during the 3rd quarter worth approximately $25,000. Covestor Ltd grew its holdings in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after purchasing an additional 200 shares during the period. Brown Brothers Harriman & Co. grew its holdings in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares during the period. West Financial Advisors LLC purchased a new stake in shares of Cooper Companies during the fourth quarter worth $49,000. Finally, Friedenthal Financial purchased a new stake in shares of Cooper Companies during the third quarter worth $50,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Trading Down 0.2 %

Shares of COO stock opened at $93.45 on Wednesday. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market capitalization of $18.65 billion, a PE ratio of 47.92, a PEG ratio of 2.41 and a beta of 1.00. The stock has a fifty day simple moving average of $94.60 and a two-hundred day simple moving average of $99.86.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the prior year, the firm earned $0.87 EPS. The business’s revenue was up 9.8% on a year-over-year basis. On average, analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on COO shares. Wells Fargo & Company raised their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Morgan Stanley dropped their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Finally, Citigroup lowered their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.